NEWS HEADLINE:bit.bio joins Ginkgo Bioworks Technology Network to Revolutionize Cell Therapy and Drive Innovation in Biotechnology IndustryARTICLE:CAMBRIDGE, England & BOSTON - In a major development for the biotechnology industry, bit.bio, the pioneering company specializing in coding human cells for groundbreaking therapeutics, has been announced as an inaugural partner of the Ginkgo Technology Network. The network, introduced today, aims to establish an exceptional ecosystem of cutting-edge technology partners, dedicated to collaborating with Ginkgo Bioworks - a leader in cell programming and biosecurity - to deliver integrated capabilities that will foster success for customers and push the boundaries of innovation.The partnership between bit.bio and Ginkgo Bioworks is poised to revolutionize the field of cell therapy, opening up new possibilities and potential for novel cures. By combining bit.bio s expertise in coding human cells with Ginkgo Bioworks leading platform in cell programming and biosecurity, the transformative potential of cell therapy will be unleashed.
bit.bio joins Ginkgo Bioworks’ Technology Network to Uphold Cell Therapy and Drive Innovation in Biotechnology IndustryARTICLE:CAMBRIDGE, England & BOSTON - In a major development for the biotechnology industry, bit.bio, the pioneering company specializing in coding human cells for groundbreaking therapeutics, has been announced as an inaugural partner of the Ginkgo Technology Network...
Published |
Modified
CSIMarket Newsroom | CSIMarket.com
CSIMarket Newsroom | CSIMarket.com
Source for this article: Based on Ginkgo Bioworks Holdings Inc ’s official statement
For details on how CSIMarket validates financial and corporate news, please review our
Editorial Standards & Fact-Checking Policy
.
Comments